1. Home
  2. CTKB vs AIIO Comparison

CTKB vs AIIO Comparison

Compare CTKB & AIIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • AIIO
  • Stock Information
  • Founded
  • CTKB 1990
  • AIIO N/A
  • Country
  • CTKB United States
  • AIIO United Arab Emirates
  • Employees
  • CTKB N/A
  • AIIO N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AIIO Auto Manufacturing
  • Sector
  • CTKB Health Care
  • AIIO Industrials
  • Exchange
  • CTKB Nasdaq
  • AIIO Nasdaq
  • Market Cap
  • CTKB 526.7M
  • AIIO 468.5M
  • IPO Year
  • CTKB 2021
  • AIIO N/A
  • Fundamental
  • Price
  • CTKB $4.02
  • AIIO $1.26
  • Analyst Decision
  • CTKB Hold
  • AIIO
  • Analyst Count
  • CTKB 4
  • AIIO 0
  • Target Price
  • CTKB $6.00
  • AIIO N/A
  • AVG Volume (30 Days)
  • CTKB 1.0M
  • AIIO 456.2K
  • Earning Date
  • CTKB 11-04-2025
  • AIIO 11-02-2025
  • Dividend Yield
  • CTKB N/A
  • AIIO N/A
  • EPS Growth
  • CTKB N/A
  • AIIO N/A
  • EPS
  • CTKB N/A
  • AIIO N/A
  • Revenue
  • CTKB $196,035,000.00
  • AIIO $11,995,000.00
  • Revenue This Year
  • CTKB $0.09
  • AIIO N/A
  • Revenue Next Year
  • CTKB $7.45
  • AIIO N/A
  • P/E Ratio
  • CTKB N/A
  • AIIO N/A
  • Revenue Growth
  • CTKB N/A
  • AIIO N/A
  • 52 Week Low
  • CTKB $2.37
  • AIIO $0.30
  • 52 Week High
  • CTKB $7.63
  • AIIO $3.48
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 53.78
  • AIIO N/A
  • Support Level
  • CTKB $3.85
  • AIIO N/A
  • Resistance Level
  • CTKB $4.23
  • AIIO N/A
  • Average True Range (ATR)
  • CTKB 0.17
  • AIIO 0.00
  • MACD
  • CTKB -0.04
  • AIIO 0.00
  • Stochastic Oscillator
  • CTKB 40.70
  • AIIO 0.00

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About AIIO Robo.ai Inc. Class B Ordinary Shares

Robo.ai Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world. Geographically, the company operates in The United States, The United Arab Emirates, Mainland China.

Share on Social Networks: